Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
361-01-007 ISMRM Abstract

MRI-based Models Using Habitat Imaging for Predicting Distinct Vascular Patterns in Hepatocellular Carcinoma

Primary: Body - Liver
Secondary: Analysis Methods - Radiomics
361-01-007 · Advanced Quantitative Liver MRI: Radiomics, Elastography, and AI · Monday, 11 May, 8:20 AM–9:15 AM · Digital Posters Row B
Keywords: Cancer Machine Learning/Artificial Intelligence Habitat Magnetic Resonance Imaging (MRI)
Accepted
Enjie Zhou 1, Chengyu Ding2, Tao Zhang3
1Nantong University, Nantong, China
2Bayer Healthcare, Wuhan, China
3Nantong Third People’s Hospital, Nantong, China
Presenting Author: Enjie Zhou

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249. doi: 10.3322/caac.21660. [doi]
2. Erstad DJ, Tanabe KK. Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma. Ann Surg Oncol. 2019;26(5):1474-1493. doi: 10.1245/s10434-019-07227-9. [doi]
3. Fang JH, Zhou HC, Zhang C, et al. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner. Hepatology. 2015;62(2):452-465. doi: 10.1002/hep.27760. [doi]
4. Wang M, Cao L, Wang Y, Huang H, Tian X, Lei J. The prognostic value of vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Clin Transl Oncol. 2024;26(8):2037-2046. doi: 10.1007/s12094-024-03427-2. [doi]
5. Woo HY, Rhee H, Yoo JE, et al. Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects. Liver Int. 2022;42(1):199-209. doi: 10.1111/liv.15051. [doi]
6. Rauch GM. Precision Imaging: One Step Closer to Pretreatment Prediction of Breast Cancer Response to Neoadjuvant Systemic Therapy. Radiology. 2023;308(1):e231482. doi: 10.1148/radiol.231482. [doi]
7. Li S, Dai Y, Chen J, Yan F, Yang Y. MRI-based habitat imaging in cancer treatment: current technology, applications, and challenges. Cancer Imaging. 2024;24(1):107. doi: 10.1186/s40644-024-00758-9. [doi]
8. Yu Y, Fan Y, Wang X, et al. Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma. Eur Radiol. 2022;32(2):959-970. doi: 10.1007/s00330-021-08250-9. [doi]
9. Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol. 2019;70(6):1133-1144. doi: 10.1016/j.jhep.2019.02.023. [doi]
10. Qu Q, Liu Z, Lu M, et al. Preoperative Gadoxetic Acid-Enhanced MRI Features for Evaluation of Vessels Encapsulating Tumor Clusters and Microvascular Invasion in Hepatocellular Carcinoma: Creating Nomograms for Risk Assessment. J Magn Reson Imaging. 2024;60(3):1094-1110. doi: 10.1002/jmri.29187. [doi]
11. Ye G, Wu G, Zhang C, et al. CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer. Frontiers in Immunology 2024;15. doi: 10.3389/fimmu.2024.1414954. [doi]
12. Shi Z, Huang X, Cheng Z, et al. MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer. Radiology 2023;308. doi: 10.1148/radiol.222830. [doi]
13. Zhang Y, Chen J, Yang C, Dai Y, Zeng M. Preoperative prediction of microvascular invasion in hepatocellular carcinoma using diffusion-weighted imaging-based habitat imaging. Eur Radiol. 2024;34(5):3215-3225. doi: 10.1007/s00330-023-10339-2. [doi]
14. Wu J, Cao G, Sun X, et al. Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy. Radiology. 2018;288(1):26-35. doi: 10.1148/radiol.2018172462. [doi]
15. Zhang Y, Yang C, Qian X, Dai Y, Zeng M. Evaluate the Microvascular Invasion of Hepatocellular Carcinoma (≤5 cm) and Recurrence Free Survival with Gadoxetate Disodium-Enhanced MRI-Based Habitat Imaging. J Magn Reson Imaging. 2024;60(4):1664-1675. doi: 10.1002/jmri.29207. [doi]
16. Chang Y, Guo T, Zhu B, Liu Y. A novel nomogram for predicting microvascular invasion in hepatocellular carcinoma. Ann Hepatol. 2023;28(6):101136. doi: 10.1016/j.aohep.2023.101136. [doi]
17. Meng XP, Tang TY, Zhou Y, et al. Predicting post-resection recurrence by integrating imaging-based surrogates of distinct vascular patterns of hepatocellular carcinoma. JHEP Rep. 2023;5(9):100806. doi: 10.1016/j.jhepr.2024.101059. [doi]
18. Lin WP, Xing KL, Fu JC, et al. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma. JAMA Netw Open. 2021;4(9):e2125055. doi: 10.1001/jamanetworkopen.2021.25055. [doi]
19. Nevola R, Tortorella G, Rosato V, et al. Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma. Biology (Basel). 2023;12(7):984. doi: 10.3390/biology12070984. [doi]
20. Zhou HC, Liu CX, Pan WD, et al. Dual and opposing roles of the androgen receptor in VETC-dependent and invasion-dependent metastasis of hepatocellular carcinoma. J Hepatol. 2021;75(4):900-911. doi: 10.1016/j.jhep.2021.04.053. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/361-01-007